HBK Investments’s CONMED CNMD Stock Holding History

HBK Investments’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,720	Closed	-$644K	–	443
2022 Q2	$644K	Buy	+6,720	New	+$806K	﹤0.01%	432
2019 Q1	–	Sell	-4,700	Closed	-$302K	–	1101
2018 Q4	$302K	Buy	+4,700	New	+$322K	﹤0.01%	1034
2018 Q3	–	Sell	-4,300	Closed	-$315K	–	1188
2018 Q2	$315K	Buy	+4,300	New	+$292K	﹤0.01%	898
2016 Q2	–	Sell	-25,173	Closed	-$1.06M	–	973
2016 Q1	$1.06M	Sell	25,173 -35,527	-59%	-$1.39M	0.01%	575
2015 Q4	$2.67M	Buy	60,700 +19,200	+46%	+$833K	0.02%	347
2015 Q3	$1.98M	Buy	41,500 +18,638	+82%	+$1.02M	0.02%	423
2015 Q2	$1.33M	Buy	+22,862	New	+$1.23M	0.01%	499

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HBK Investments's CNMD Position: Q3 2022 in Review

HBK Investments sold out of CONMED (CNMD) in Q3 2022, closing a stake of 6,720 shares — an estimated $644K sold.

HBK Investments first reported a position in CNMD in Q2 2015 and held it in 7 quarters. The position peaked at $2.67M in Q4 2015. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

HBK Investments reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
HBK Investments sold 6,720 CONMED shares in Q3 2022, an estimated $644K.
HBK Investments first reported a position in CONMED in Q2 2015 and held it in 7 quarters.
HBK Investments's CONMED position peaked at $2.67M in Q4 2015.
252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.